Mei-Chiou Shen

2PUBLICATIONS
10CO-AUTHORS
Air pollution modelling and controlMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Apr 13, 2023
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib.

Ming-Ju Tsai, Jen-Yu Hung, Juei-Yang Ma

|Apr 29, 2022
Proton pump inhibitors reduce the survival of advanced lung cancer patients with therapy of gefitinib or erlotinib.

Chia-Han Lee, Mei-Chiou Shen, Ming-Ju Tsai

Pageof 1

Frequent Collaborators

2 joint publications

Ming-Ju Tsai

1 joint publications

Jung-San Chang

1 joint publications

Yaw-Bin Huang

1 joint publications

Yi-Hsin Yang

1 joint publications

Kun-Pin Hsieh

1 joint publications

Jen-Yu Hung

1 joint publications

Kuan-Li Wu

1 joint publications

Cheng-Hao Chuang

1 joint publications

Chih-Jen Yang

1 joint publications

Inn-Wen Chong

Frequent Collaborators

2 joint publications

Ming-Ju Tsai

1 joint publications

Jung-San Chang

1 joint publications

Yaw-Bin Huang

1 joint publications

Yi-Hsin Yang

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
See more related videos